[HTML][HTML] European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European journal of …, 2020 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated …

[HTML][HTML] Risk factors and diagnosis of advanced cutaneous squamous cell carcinoma

G Brancaccio, G Briatico, C Pellegrini… - Dermatology Practical …, 2021 - ncbi.nlm.nih.gov
Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer affecting
humans. The combination of the increasing incidence and high mortality in advanced stages …

[HTML][HTML] European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European Journal of …, 2023 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
white populations, accounting for 20% of all cutaneous malignancies. Overall, cSCC mostly …

What is a solitary keratoacanthoma? A benign follicular neoplasm, frequently associated with squamous cell carcinoma

A Ogita, S Ansai - Diagnostics, 2021 - mdpi.com
We present histopathological criteria for diagnosing keratoacanthoma (KA). In KA, four
histological stages are recognized, which are the early/proliferative stage, well-developed …

Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma

RA Carr, D Mesiano, C Heffron, T Radonic, J Wiggins… - Pathology, 2023 - Elsevier
Keratoacanthoma (KA) is widely considered a benign, usually self-resolving, neoplasm
distinct from cutaneous squamous cell carcinoma (cSCC), while some consider KA to be …

Histological classification of cutaneous squamous cell carcinomas with different severity

L Schmitz, J Kanitakis - Journal of the European Academy of …, 2019 - Wiley Online Library
Cutaneous squamous cell carcinoma (cSCC) is the second most common non‐melanoma
skin cancer. Histology represents the gold standard to confirm the diagnosis of cSCC and is …

Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations

R Gupta, CI Selinger, B Ashford, MST Chua, JR Clark… - Pathology, 2023 - Elsevier
Non-melanocytic skin cancers (NMSCs) account for five times the incidence of all other
cancers combined and cost US $6 billion annually. These are the most frequent specimens …

Japanese dermatological association guidelines: outlines of guidelines for cutaneous squamous cell carcinoma 2020

S Ansai, Y Umebayashi, N Katsumata… - The Journal of …, 2021 - Wiley Online Library
In consideration of the development of treatment options for squamous cell carcinoma
(SCC), the Japanese Skin Cancer Society issued the first guidelines of SCC in 2007 and …

Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization

M Muscheck, H Abol-Enein, K Chew, D Moore… - …, 2000 - academic.oup.com
The development of bladder tumors has been associated with a number of causative agents,
including schistosomiasis. Schistosome-related cancers show different clinical and …

Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker

GR Fraga, P Chow - Journal of Cutaneous Pathology, 2020 - Wiley Online Library
Background Histopathologic distinction between keratoacanthoma (KA) and squamous cell
carcinoma (SCC) is challenging. We surmised that a discriminatory immunostain would be …